Chemotherapeutics-induced Oct4 expression contributes to drug resistance and tumor recurrence in bladder cancer
Open Access
- 9 May 2016
- journal article
- research article
- Published by Impact Journals, LLC in Oncotarget
- Vol. 8 (19) , 30844-30858
Abstract
Chemotherapeutics-induced Oct4 expression contributes to drug resistance and tumor recurrence in bladder cancer Chemotherapeutics-induced Oct4 expression contributes to drug resistance and tumor recurrence in bladder cancerKeywords
This publication has 58 references indexed in Scilit:
- Prothymosin α overexpression contributes to the development of pulmonary emphysemaNature Communications, 2013
- Understanding and targeting cancer stem cells: therapeutic implications and challengesActa Pharmacologica Sinica, 2013
- Retinoic acid represses invasion and stem cell phenotype by induction of the metastasis suppressors RARRES1 and LXNOncogenesis, 2013
- Acquired cancer stem cell phenotypes through Oct4-mediated dedifferentiationOncogene, 2012
- Drug-induced Senescence Generates Chemoresistant Stemlike Cells with Low Reactive Oxygen SpeciesJournal of Biological Chemistry, 2011
- Octamer 4 (Oct4) mediates chemotherapeutic drug resistance in liver cancer cells through a potential Oct4–AKT–ATP‐binding cassette G2 pathway†Hepatology, 2010
- Ovarian cancer stem-like side-population cells are tumourigenic and chemoresistantBritish Journal of Cancer, 2010
- Highly tumorigenic lung cancer CD133 + cells display stem-like features and are spared by cisplatin treatmentProceedings of the National Academy of Sciences, 2009
- Analyzing real-time PCR data by the comparative CT methodNature Protocols, 2008
- Cellular processing of platinum anticancer drugsNature Reviews Drug Discovery, 2005